Navigation Links
Studies Published in Pain Medicine Demonstrate Effectiveness of Minimally-Invasive Cooled Radiofrequency Treatment for Low Back Pain
Date:3/1/2013

ROSWELL, Ga., March 1, 2013 /PRNewswire/ -- Kimberly-Clark today announced the publication of two separate studies that achieved positive outcomes following use of cooled radiofrequency (RF) to treat discogenic and sacroiliac joint (SIJ) pain in the low back. The studies evaluated Kimberly-Clark's TransDiscal Cooled Radiofrequency System and SInergy Cooled Radiofrequency System and demonstrated that both treatment options provided patients who suffer from chronic low back pain with much-needed pain relief and improved quality of life benefits. Results were published in Pain Medicine, the official journal of the American Academy of Pain Medicine, the Faculty of Pain Medicine of the Australian and New Zealand College of Anesthetists, and the International Spine Intervention Society.

(Logo: http://photos.prnewswire.com/prnh/20110928/DA76879LOGO)

Dr. Leonardo Kapural of Carolinas Pain Institute and Wake Forest Brookstown Pain Center in Winston-Salem, N.C., led the first-of-its-kind double-blinded randomized controlled trial study of 59 patients with 29 randomized to intradiscal biacuplasty (IDB) and 30 to the control group. Participating patients had a history of chronic low back pain persisting six months or longer. This type of pain is extremely debilitating, and it dramatically limits an individual's everyday activities such as sitting and driving. At the six-month follow-up, patients treated with Kimberly-Clark's TransDiscal Cooled RF
'/>"/>

SOURCE Kimberly-Clark
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
2. First assessment of individual RLS domains in new post-hoc analyses of Neupro® studies
3. Southern Research Signs Agreement with Apath, LLC to Conduct Preclinical Studies with Virus-Based HCV Screenings
4. Unigenes Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies
5. Agendia Announces Nine Studies in Breast and Colon Cancer for Presentation at 2012 Annual Meeting of the American Society of Clinical Oncology (ASCO)
6. Lilly and Boehringer Ingelheim Present Data at the 72nd American Diabetes Association Scientific Sessions® from Phase II Studies Comparing Investigational Novel Basal Insulin to Insulin Glargine
7. Abbott Presents Results of Clinical Studies Evaluating Its Investigational Treatment for Advanced Parkinsons Disease
8. Lexicon Announces Publication of Results of Two Studies of LX4211 in Patients with Type 2 Diabetes in the Journal Clinical Pharmacology & Therapeutics
9. Pulse Oximetry Screening Hailed as the New Milestone to Combat Critical Congenital Heart Disease - Signal Extraction Technology Leading the Way in Large, Independent Clinical Studies
10. Omeros Successfully Completes Preclinical Studies of OMS824 for Schizophrenia and Phase 1 Clinical Trial Preparations Underway
11. Pressure BioSciences Patented PCT Platform Shown to Significantly Improve Protein and DNA Detection in Multiple Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... 24, 2014  Uroplasty, Inc. (NASDAQ: UPI ... and markets innovative proprietary products to treat voiding ... 2015 first quarter ended June 30, 2014.  ... Neuromodulation System grew 19% to $4.1 million, as ... of the prior year.  Total revenue for the ...
(Date:7/24/2014)... Ohio, July 24, 2014  Mettler-Toledo International Inc. (NYSE: ... for 2014.  Provided below are the highlights: ... the quarter compared with the prior year. Reported sales ... , Net earnings per diluted share as reported ... quarter of 2013. Adjusted EPS was $2.57, an increase ...
(Date:7/24/2014)... THOUSAND OAKS, Calif. , July 24, 2014 ... will report its second quarter financial results on Tuesday, July ... The announcement will be followed by a conference call with ... call from Amgen will be Robert A. Bradway , ... senior management team. Live audio of the conference ...
Breaking Medicine Technology:Uroplasty Reports Fiscal First Quarter Results 2Uroplasty Reports Fiscal First Quarter Results 3Uroplasty Reports Fiscal First Quarter Results 4Uroplasty Reports Fiscal First Quarter Results 5Uroplasty Reports Fiscal First Quarter Results 6Uroplasty Reports Fiscal First Quarter Results 7Uroplasty Reports Fiscal First Quarter Results 8Uroplasty Reports Fiscal First Quarter Results 9Uroplasty Reports Fiscal First Quarter Results 10Uroplasty Reports Fiscal First Quarter Results 11Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 2Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 3Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 4Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 5Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 6Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 7Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 8Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 9Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 10Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 11Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 12Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 13Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 14Amgen Announces Webcast of 2014 Second Quarter Financial Results 2
... Facility, VIENNA, Va., Aug. 14 CEL-SCI CORPORATION,(Amex: ... into an agreement with a,biomedical real estate group under ... facility for its cancer drug Multikine(R). The,financial value of ... is located near Baltimore, Maryland. Once fully built out ...
... ALTO, Calif., Aug. 15 CV Therapeutics,Inc. (Nasdaq: ... developed jointly,by the American College of Cardiology Foundation ... week,s issue of Circulation, state that,"ranolazine may be ... Ranexa(R) (ranolazine extended-release tablets) is indicated for the,treatment ...
Cached Medicine Technology:CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug 2CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug 3CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug 4Ranexa(R) Added to New ACC/AHA Guidelines on Unstable Angina/Non ST-Elevation Myocardial Infarction (UA/NSTEMI) 2
(Date:7/24/2014)... July 24, 2014 The federal ... ) in the U.S. District Court, District ... for plaintiff medical information covered by the federal ... the July 16th Order, U.S. District Judge Douglas ... Fresenius Medical Care the right to receive HIPAA- ...
(Date:7/24/2014)... American Society of Association Executives (ASAE) announced its 2014 ... of the American Society of Anesthesiologists (ASA). , ... Power of A Gold Award, one of the top ... the betterment of the world through education on the ... improve anesthesia care. , ASA was also honored with ...
(Date:7/24/2014)... July 24, 2014 Pools and beaches are ... water can be dangerous, especially for small children, so ... safety. , According to the Centers for Disease Control and ... most at risk for water-related injuries and deaths. It’s important ... around water, so Amica is offering the following tips from ...
(Date:7/24/2014)... News Facts , Lexmark’s ... certification for compliance with Department of Defense (DoD) ... DoD Information Assurance Certification and Accreditation Process (DIACAP). ... the DoD as the Enterprise Clinical Imaging Archive, ... the U.S. Army Medical Materiel Agency. , DIACAP ...
(Date:7/24/2014)... July 24, 2014 A new study led ... into the interplay among bacteria, viruses and the immune ... men,s infectivity their potential to infect others ... produce large amounts of virus in their semen despite ... "compartmentalization," where different levels of the virus can be ...
Breaking Medicine News(10 mins):Health News:GranuFlo Lawsuits Move Forward in Federal Court, With Issuance of Protective Order for HIPAA Information, Bernstein Liebhard LLP Reports 2Health News:GranuFlo Lawsuits Move Forward in Federal Court, With Issuance of Protective Order for HIPAA Information, Bernstein Liebhard LLP Reports 3Health News:GranuFlo Lawsuits Move Forward in Federal Court, With Issuance of Protective Order for HIPAA Information, Bernstein Liebhard LLP Reports 4Health News:Keep Kids Safe in the Water with 5 Tips from Amica 2Health News:Perceptive Software Achieves DIACAP Certification for Vendor Neutral Archive Solution to Support U.S. Department of Defense Integrated Clinical Systems Program 2Health News:Perceptive Software Achieves DIACAP Certification for Vendor Neutral Archive Solution to Support U.S. Department of Defense Integrated Clinical Systems Program 3Health News:Perceptive Software Achieves DIACAP Certification for Vendor Neutral Archive Solution to Support U.S. Department of Defense Integrated Clinical Systems Program 4Health News:TGen-led study seeks to understand why some HIV-positive men are more infectious 2
... may pride themselves on being highly evolved, most still ... choosing a mate, according to research by Indiana University ... and colleagues found that though individuals may claim otherwise, ... the much choosier of the sexes, leverage their looks ...
... the religious beliefs and practices of American physicians has ... is psychiatry. Among psychiatrists who have a religion, more ... are Protestant or Catholic, the two most common religions ... September 2007 issue of Psychiatric Services, also found that ...
... 12 to 19 years who received family-based treatment were ... those who received supportive psychotherapy, which explores the underlying ... the September issue of Archives of General Psychiatry, one ... a disabling eating disorder with a prevalence of 1 ...
... Deer Run, 360 White Deer Run Road, ... Treatment Gap of One Million Needing Treatment vs. 90,000 ... Obtaining Help, WDR Parent CRC Health Group CEO Dr. ... Officials, State Representatives, HARRISBURG, Pa., ...
... September 3 - QUANTEL has Entered Into ... the Company WaveLight Aesthetic GmbH A strong complementarity ... WaveLight AG, is,specialized in Dermatology/Aesthetic lasers. It is based ... estimated of approx. 10MEUR,for the fiscal year 2006/2007 ended ...
... schizophrenia, INDIANAPOLIS, Sept. 2 An investigational,phase II ... for the first time in humans a drug that ... antipsychotic activity. The study,was sponsored by Eli Lilly and ... - a randomized, double-blind, placebo-controlled clinical,trial - patients were ...
Cached Medicine News:Health News:Choosing a mate: what we really want 2Health News:Psychiatrists are the least religious of all physicians 2Health News:Psychiatrists are the least religious of all physicians 3Health News:Family-based treatment more effective than supportive psychotherapy in treating bulimia 2Health News:4-Star Gen. Barry McCaffrey, Former U.S. Drug Czar, to Address National Drug Crisis, Keynote Grand Opening of New Allenwood, PA 'National Model' Detox Center 2Health News:QUANTEL Intends to Strengthen its Dermatology/ Aesthetics Division With the Acquisition of WaveLight Aesthetic GmbH 2Health News:Investigational Agent Targeting Metabotropic Glutamate 2/3 Receptors Demonstrates Antipsychotic Activity in Humans, Study in Nature Medicine Finds 2Health News:Investigational Agent Targeting Metabotropic Glutamate 2/3 Receptors Demonstrates Antipsychotic Activity in Humans, Study in Nature Medicine Finds 3Health News:Investigational Agent Targeting Metabotropic Glutamate 2/3 Receptors Demonstrates Antipsychotic Activity in Humans, Study in Nature Medicine Finds 4Health News:Investigational Agent Targeting Metabotropic Glutamate 2/3 Receptors Demonstrates Antipsychotic Activity in Humans, Study in Nature Medicine Finds 5Health News:Investigational Agent Targeting Metabotropic Glutamate 2/3 Receptors Demonstrates Antipsychotic Activity in Humans, Study in Nature Medicine Finds 6
Steroid-eluting, screw-in pacing lead...
... one of the world's thinnest, ... a 7 F introducer, the ... designed to lower the incidence ... introduction in smaller, more tortuous ...
... Vitatron Crystalline Active fixation lead series ... new extendable retractable helix mechanism, specifically ... the pacemaker system, reducing the sensing ... The Crystalline Active fixation leads allow ...
... 6491 unipolar pediatric temporary pacing ... atrial and ventricular sensing and ... surgery. This temporary pacing lead ... the ideal lead for pediatric ...
Medicine Products: